z-logo
Premium
Impact of graft thickness reduction of left lateral segment on outcomes following pediatric living donor liver transplantation
Author(s) -
Kitajima Toshihiro,
Sakamoto Seisuke,
Sasaki Kengo,
Narumoto Soichi,
Kazemi Kourosh,
Hirata Yoshihiro,
Fukuda Akinari,
Imai Rumi,
Miyazaki Osamu,
Irie Rie,
Teramukai Satoshi,
Uemoto Shinji,
Kasahara Mureo
Publication year - 2018
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.14875
Subject(s) - medicine , surgery , living donor liver transplantation , intensive care unit , transplantation , liver transplantation
Reducing graft thickness is essential to prevent large‐for‐size graft problems in pediatric living donor liver transplantation ( LDLT ). However, long‐term outcomes of LDLT using reduced‐thickness left lateral segment ( LLS ) grafts are unclear. In 89 patients who underwent LDLT using reduced LLS grafts between 2005 and 2017, short‐term and long‐term outcomes were compared between a nonanatomically reduced LLS ( NAR ‐ LLS ) graft group and a reduced‐thickness LLS graft group. Estimated blood loss was lower and abdominal skin closure was less needed in the recipient operation in the reduced‐thickness LLS graft group. Postoperatively, portal vein ( PV ) flow was significantly decreased in the NAR ‐ LLS graft group, and there was shorter intensive care unit (ICU) stay and fewer postoperative complications, especially bacteremia, in the reduced‐thickness LLS graft group. Graft survival at 1 and 3 years after LDLT using reduced‐thickness LLS grafts was 95.2% and 92.4%, respectively, which was significantly better than for NAR ‐ LLS grafts. Multivariate analysis revealed that fulminant liver failure, hepatofugal PV flow before LDLT , and NAR ‐ LLS graft were associated with poor graft survival. In conclusion, LDLT using reduced‐thickness LLS grafts is a safe and feasible option with better short‐ and long‐term outcomes in comparison with NAR ‐ LLS grafts.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom